Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancerJeanne Tie, Peter Gibbs, Yuxuan Wang et al.|Science Translational Medicine|2016Cited by 1.5k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSun Young Rha, Xiaochun Zhang, Do‐Youn Oh et al.|The Lancet Oncology|2023Cited by 614
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100Markus Moehler, Yung‐Jue Bang, Sara Lonardi et al.|Journal of Clinical Oncology|2020Cited by 222